Neovasc.com

Ping response time 2ms Excellent ping
Domain provide by godaddy.com. Domain ID : 88390402_DOMAIN_COM-VRSN
Created : 2002-07-14T15:09:36Z. Expired: 2025-07-14T15:09:36Z (0 Years, 245 Days left)
Host name aec037177372cc6cd.awsglobalaccelerator.com, IP address: 15.197.225.128, location: United States

System updated on 2024/11/11

Keyword Suggestion

Neovascularization

Neovascular glaucoma

Neovascular amd

Neovascular age related macular degeneration

Neovasc

Neovascularization cornea

Neovascularization eye

Neovascular glaucoma icd 10

Neovascularization of the iris

Neovascular amd with active cnv od icd 10

Neovasculgen

Neovascularization meaning

Neovascular amd with active cnv os icd 10

Neovascular amd icd 10

Neovascular macular degeneration

Neovascular amd with active cnv

Neovasc.com lookup results from whois.godaddy.com server:

Network

Owner

Abuse

Technical support

Domain Provider	Number Of Domains
godaddy.com	286730
namecheap.com	101387
networksolutions.com	69118
tucows.com	52617
publicdomainregistry.com	39120
whois.godaddy.com	32793
enomdomains.com	23825
namesilo.com	21429
domains.google.com	21384
cloudflare.com	20573
gmo.jp	18110
name.com	17601
fastdomain.com	14708
register.com	13495
net.cn	12481
ionos.com	12416
ovh.com	12416
gandi.net	12305
registrar.amazon.com	12111

Host Informations

Check all domain's dns records

See Web Sites Hosted on 15.197.225.128

Fetching Web Sites Hosted

Site Inspections

Loading ...

Port Scanner (IP: 15.197.225.128)

› Ftp: 21

› Ssh: 22

› Telnet: 23

› Smtp: 25

› Dns: 53

› Http: 80

› Pop3: 110

› Portmapper, rpcbind: 111

› Microsoft RPC services: 135

› Netbios: 139

› Imap: 143

› Ldap: 389

› Https: 443

› SMB directly over IP: 445

› Msa-outlook: 587

› IIS, NFS, or listener RFS remote_file_sharing: 1025

› Lotus notes: 1352

› Sql server: 1433

› Point-to-point tunnelling protocol: 1723

› My sql: 3306

› Remote desktop: 3389

› Session Initiation Protocol (SIP): 5060

› Virtual Network Computer display: 5900

› X Window server: 6001

› Webcache: 8080

Spam Check (IP: 15.197.225.128)

› Dnsbl-1.uceprotect.net:

› Dnsbl-2.uceprotect.net:

› Dnsbl-3.uceprotect.net:

› Dnsbl.dronebl.org:

› Dnsbl.sorbs.net:

› Spam.dnsbl.sorbs.net:

› Bl.spamcop.net:

› Recent.dnsbl.sorbs.net:

› All.spamrats.com:

› B.barracudacentral.org:

› Bl.blocklist.de:

› Bl.emailbasura.org:

› Bl.mailspike.org:

› Bl.spamcop.net:

› Cblplus.anti-spam.org.cn:

› Dnsbl.anticaptcha.net:

› Ip.v4bl.org:

› Fnrbl.fast.net:

› Dnsrbl.swinog.ch:

› Mail-abuse.blacklist.jippg.org:

› Singlebl.spamgrouper.com:

› Spam.abuse.ch:

› Spamsources.fabel.dk:

› Virbl.dnsbl.bit.nl:

› Cbl.abuseat.org:

› Dnsbl.justspam.org:

› Zen.spamhaus.org:

Email address with neovasc.com

Found 2 emails of this domain
1. [email protected]
2. [email protected]

Recent Searched Sites

› Radioya.es (3 seconds ago) / US

› Kara-papa.com (6 seconds ago) / JP

› Physics-and-radio-electronics.com (3 seconds ago) / US

› Ultimapharmaceuticals.com (36 seconds ago) / US

› Flirtmoms.com (2 seconds ago) / US

› Sthmmrzx.net (21 seconds ago) / CN

› Mynewsla.com (33 seconds ago) / US

› Crous-bordeaux.fr (4 seconds ago) / FR

› Lovethegarden.com (56 seconds ago) / GB

› Georgiaopenhouses.com (1 mins ago) / US

› Webpki.lacunasoftware.com (2 seconds ago) / BR

› Ecommk.com (23 seconds ago) / VN

› Siyapathaedu.com (9 seconds ago) / US

› Bonfire.com (29 seconds ago) / US

› Callofdutyzombies.com (7 seconds ago) / US

› Neovasc.com (0 seconds ago) / US

› Xygs.gusu.gov.cn (1 seconds ago) / CN

› Gems-world.com (26 seconds ago) / NL

› Tainiomania.org (25 seconds ago) / US

› Panoramaaviation.com (1 seconds ago) / CA

List of our tools

Emails by domain

Mobile Friendly Check

Page Speed Check

DNS Lookup

Ports Scan

Sites on host

Sitemap Generator

Websites Listing

We found Websites Listing below when search with neovasc.com on Search Engine

Neovasc Inc. | North America

Neovasc is a leader in the development of minimally invasive therapies for two of the most vexing challenges in cardiovascular care: refractory angina and mitral valve regurgitation. The company is committed to clinical rigor and collaborates with researchers and clinicians in Canada, the United States, Europe, and the Middle East.

Neovasc.com

Neovasc - Welcome to the

Neovasc eIFU System This website and all its content are intended for healthcare professionals only. Please note that the content of the instructions for use may vary based on the regulatory requirements in each country.

Ifu.neovasc.com

Accueil - Neovacs

2020-05-15 · Cette approche innovante permet d'utiliser le système immunitaire du patient pour réguler la surproduction nocive de cytokines (immunothérapie active). Nous mettons également à profit les compétences de nos équipes expérimentées pour investir dans des sociétés de développement de candidats-médicaments ( BioTech) et de dispositifs ...

Neovacs.com

Neovasc Inc. Profile - SEDAR

Neovasc Inc. Mailing Address: Suite 5138 - 13562 Maycrest Way Richmond, BC V6V 2J7: Head Office Address: Suite 5138 - 13562 Maycrest Way Richmond, BC V6V 2J7: Contact Name: Chris Clark: Principal Regulator: British Columbia: Business e-mail address: [email protected]: Short Form Prospectus Issuer: Yes: Telephone Number: 604 270-4344: Reporting ...

Sedar.com

Neovasc Inc. (NVCN) Stock Price, News, Quote & History

Find the latest Neovasc Inc. (NVCN) stock quote, history, news and other vital information to help you with your stock trading and investing.

Finance.yahoo.com

Neovasc Inc. (NVCN.TO) Stock Price, News, Quote

Neovasc Announces Direct Sales Operations in United Kingdom. Expansion Driven by NICE Guidelines and Enhanced Reimbursement for the Neovasc Reducer(TM) Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - July 5, 2022) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced that the company has …

Ca.finance.yahoo.com

Neovasc Inc. (NVCN) Latest Stock News & Headlines

Neovasc Inc. (NASDAQ: NVCN) is a medical device company focused on developing, manufacturing, and marketing products for the cardiovascular market. Neovasc is a leading developer of minimally ...

Finance.yahoo.com

NVCN Neovasc Inc — Stock Price and Discussion

2022-07-15 · Neovasc Inc NASDAQ Updated Jul 15, 2022 7:56 PM. NVCN 5.95 0.04 (0.64%). 44,294

Stocktwits.com

Neovasc Company Profile - Craft

2022-05-27 · Neovasc. Frequently Asked Questions. When was Neovasc founded?. Neovasc was founded in 2008.. Who are Neovasc key executives?. Neovasc's key executives are Fred Colen, Steve Rubin and Bill Little.. What is Neovasc revenue?. Latest Neovasc annual revenue is $2.5 m.. Who are Neovasc competitors?. Competitors of Neovasc include Ivoclar Vivadent, …

Craft.co

Neovasc - Careers and Employment: Working at Neovasc

2016-04-28 · Neovasc Careers and Employment. About the company. Company size. 51 to 200. Revenue. $5m to $30m (CAD) Headquarters. RICHMOND. Link. Neovasc website. Learn more. Reviews. Quality Systems Specialist in Richmond, BC. 3.0. on 5 June 2018. fun place to work. Enjoyed working with this company. Had a fantastic team. Good work life balance. Very good …

Ca.indeed.com

Neovasc Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch

2022-07-15 · Neovasc Inc. Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. It focuses on Neovast Tiara and Neovasc Reducer products. The company was founded on November 2 ...

Marketwatch.com

Neovasc Reducer - Products - EPS Vascular

The Neovasc Reducer™ System: A novel solution. The Reducer is a balloon expandable hourglass-shaped metal mesh. When implanted in the coronary sinus (CS) it creates a focal narrowing to modulate flow and elevate CS pressure. CS narrowing has been demonstrated to improve perfusion to ischemic territories of the myocardium10 and can lead to ...

Epsvascular.com

Neovasc Announces Effective Date of Share Consolidation

2022-04-27 · Neovasc is a specialty medical device company that develops, manufactures, and markets products for the rapidly growing cardiovascular marketplace. Its products include Reducer, for the treatment of refractory angina, which is under clinical investigation in the United States and has been commercially available in Europe since 2015, and Tiara™ for the …

Ca.news.yahoo.com

Neovasc Granted Additional 180 Calendar Day Grace Period for …

2021-11-24 · Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - November 24, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") has received written notification (the "Nasdaq Notice") from the Nasdaq Stock Market LLC ("Nasdaq") informing the Company that in accordance with Nasdaq Listing Rule …

Ca.news.yahoo.com

Neovasc Inc. (TSE:NVC) Director Doug Janzen Acquires 2,280 …

2022-07-19 · On Tuesday, July 5th, Doug Janzen acquired 1,271 shares of Neovasc stock. The shares were acquired at an average cost of C$7.67 per share, for a total transaction of C$9,745.07. On Thursday, June ...

Etfdailynews.com

Neovasc Announces Direct Sales Operations in United Kingdom

2022-07-05 · Neovasc is a specialty medical device company that develops and markets products for the rapidly growing cardiovascular marketplace. Its products include Reducer, for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and Tiara™ for the transcatheter …

Ca.finance.yahoo.com

Neovasc Inc. Profile on T-Net

Neovasc Inc. is a specialty medical device company that develops, manufactures, and markets products for the rapidly growing cardiovascular marketplace. Our products include the Tiara™ technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer™ for the treatment of refractory angina.

Bctechnology.com

Baystreet.ca - Neovasc Inc

2022-07-05 · 12:55 PM EST - Neovasc Inc : Today announced that the company has expanded its direct sales operations in Europe to include the United Kingdom, effective July 1, 2022. Neovasc Inc shares T.NVCN ...

Baystreet.ca

Neovasc - Crunchbase Company Profile & Funding

Contact Email [email protected]. Phone Number 604-270-4344. Neovasc Inc. is a specialty medical device company that develops and manufactures products for the rapidly growing cardiovascular device marketplace.Neovasc Inc. offers pericardial tissue processing, vascular product development, design, and manufacturing solutions to industry partners.

Crunchbase.com

About Neovasc Inc (NVCN) - Investing.com Canada

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical …

Ca.investing.com

Domains Expiration Date Updated

Site	Provider	Expiration Date
psbmgmt.com	enomdomains.com	-2 Years, -64 Days
medyadia.com	nicproxy.com	-2 Years, -157 Days
manualsguru.com	godaddy.com	-2 Years, -196 Days
welkinwitstech.com	godaddy.com	-2 Years, -278 Days
dinastiaadministradora.com	instra.com	-1 Years, -352 Days
tvstock.net	danesconames.com	-1 Years, -327 Days
kheddaresort.com	godaddy.com	-2 Years, -132 Days
capitolempresa.com	ionos.com	-2 Years, -5 Days
ontides.com	godaddy.com	-1 Years, -235 Days
qudswiki.org	name.com	-2 Years, -180 Days